FARMINGDALE, N.Y., June 15 /PRNewswire-FirstCall/ -- Misonix, Inc. (Nasdaq: MSON - News), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced the availability of the first edition of its Medical Device Newsletter -- HIFU Cancer Treatment and Ultrasonic Medical Technologies. The newsletter is intended to provide information pertaining to many of Misonix’s products, both commercialized as well as in the development phase. The newsletter will be made available to the public and can be accessed on Misonix’s Web site (www.misonix.com).
